“Pathogenetic mechanisms underlying contrast-induced nephropathy in coronary artery disease and type 2 diabetes patients: innovative approaches and future directions”, Je, vol. 1, no. 1, pp. 3–13, Mar. 2024, doi: 10.70626/3060-4850-2024-1-1-3-13.